Dying Patients Have Pence’s Backing on ‘Right to Try’ Policy
- VP pushes law giving dying patients access to unapproved drugs
- Bypassing FDA scrutiny for wider access to experimental drugs
This article is for subscribers only.
Vice President Mike Pence may have just picked another fight with pharmaceutical companies -- one that doesn’t involve drug prices.
Pence is pushing for a nationwide law that would give terminally ill patients expanded access to experimental drugs that haven’t been approved yet but have made it through the first of three approval phases.